Cavion, Inc. is a clinical-stage company developing first-in-class therapies to restore the brains natural rhythms by modulating overactive T-type calcium channels for a range of neurological and rare genetic diseases. Cavions mission is to combine our deep understanding of T-type calcium channel (Cav3) biology with superior chemistry and clinical research expertise to provide therapeutics that will improve peoples lives. As we work to bring these therapies to market, Cavion will innovatively improve all aspects of trial conduct and patient engagement.
Cavion, Inc. is a clinical-stage company developing first-in-class therapies to restore the brains natural rhythms by modulating overactive T-type calcium channels for a range of neurological and rare genetic diseases. Cavions mission is to combine our deep understanding of T-type calcium channel (Cav3) biology with superior chemistry and clinical research expertise to provide therapeutics that will improve peoples lives. As we work to bring these therapies to market, Cavion will innovatively improve all aspects of trial conduct and patient engagement.